CSU.TO
🇨🇦TSXCanadian TechnologyConstellation Software Inc.
6-factor analysis
One or more factors show N/A — Finnhub data is incomplete for this ticker. Neutral 50 used as baseline. Methodology
Scores refresh daily · How scores work
5-year price history
- Constellation deployed ~CA$1.6B in acquisitions in the first 4.5 months of 2026 alone — more than all of 2025 — with LTM acquisitions as a percentage of FCFA2S crossing 100%, definitively refuting the bear thesis that CSU is too large to compound efficiently.
- Revenue grew 15% to CA$11.6B in 2025 with 6% organic growth, and analysts project adjusted EPS to nearly double from US$79 in 2024 to US$190 by 2030 — one of the highest-quality compounders on the TSX for long-term Canadian investors.
- CSU's vertical market software portfolio serves mission-critical government, healthcare, and infrastructure clients with near-100% revenue retention — feared AI-driven churn has not materialized, validating the stickiness of its niche SaaS businesses.
- Founder Mark Leonard resigned as President on September 25, 2025 for health reasons — an unplanned departure for a business where Leonard's capital allocation philosophy is essentially the product, creating genuine succession uncertainty.
- Maintenance and recurring revenue organic growth decelerated from 6% in Q4 2025 to 4% (FX-neutral) in Q1 2026 — below CSU's long-term average of 4.8% since 2019 — and initial cash returns on the 2024 acquisition cohort are tracking below historical norms.
- At a high P/E multiple with a 6.1% net margin, CSU offers minimal margin of safety on pure earnings metrics — in the bear case, multiple compression alone without any operational deterioration could generate flat to negative returns over a 2–3 year horizon.
Constellation Software is the closest thing Canadian investors have to a Berkshire Hathaway — a capital allocation machine that compounds quietly and has never once needed to explain itself to the market. There's no dividend, no buyback, no analyst guidance. Just acquisitions. For a TFSA, it's an extraordinary compounder: you simply buy it and leave it. The only question is whether the price already reflects the next decade of great acquisitions.
| Account | Fit | Why |
|---|---|---|
| TFSA | Ideal | No dividend means no tax drag; all value creation is capital appreciation compounding tax-free. The perfect TFSA compounder. |
| RRSP | Good | Tax-deferred capital appreciation. Works well as a long-term RRSP holding. |
| FHSA | Good | Strong compounder for a 3–5 year FHSA horizon — high conviction required given the valuation. |
| Non-reg | OK | Capital gains on disposition taxed at 50% inclusion, but buy-and-hold strategy minimises realisation events. |
Ideal = best tax outcome · Avoid = material drag or ineligible · Color and symbol, not color alone, indicate fit.
The Brief. Every Sunday.
One featured Canadian stock. One tax or account tip. One TSX market note. Clear, direct, done in under 10 minutes. Free.
- • One featured Canadian stock with a full thesis
- • A tax or account tip — TFSA, RRSP, eligible dividends
- • TSX market context in one sentence
- • Unsubscribe in one click. No filler.
By subscribing you agree to our privacy policy. Educational only — not investment advice.